ND Biosciences
PrivateLast Round
Seed
Oct 11, 2022
Total Funding Raised
$110,000
Company Overview
ND Biosciences operates in Healthcare & Life Sciences and is based in Epalinges. Its latest recorded funding round was a Seed round in October 2022.
ND Biosciences is a biotechnology company that develops next-generation therapeutics and diagnostics for neurodegenerative diseases like Parkinson's and Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ND Biosciences Comparables
Compare ND Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ResQ Biotech | 80% | |
| Innoprot | 72% | |
| AC Immune SA | 68% |
For institutional investors. Book with your work email.
ND Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 11, 2022 | ||||
| Seed | Aug 3, 2020 | ||||
| Grant | Oct 2, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ND Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Technological Innovation | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 91% MoM.
- Apr 18, 2026
Monthly visitors increased 258% MoM.
For institutional investors. Book with your work email.
ND Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ND Biosciences's valuation, stock price, and market status.
Is ND Biosciences a public or private company?
ND Biosciences is a private company.
What is the current stock price of ND Biosciences?
ND Biosciences is a private company, so its shares have no public market price. Caplight tracks ND Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ND Biosciences worth (valuation)?
Valuation information for ND Biosciences is not publicly available.
Can I buy ND Biosciences stock?
ND Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ND Biosciences's last funding round?
ND Biosciences's most recent funding round was Seed on October 11, 2022.
Who are the main investors in ND Biosciences?
Key investors in ND Biosciences include Foundation for Technological Innovation, The Michael J. Fox Foundation for Parkinson's Research.
Will ND Biosciences IPO soon?
No public IPO plans have been announced for ND Biosciences.
How can I track ND Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in ND Biosciences's shares on secondary markets.